10-Q quarterly report · filed Nov 5, 2026

CVRx, Inc. (CVRX) Q3 2026 10-Q Quarterly Report

Short answer

CVRx, Inc. (CVRX) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $14M (down 5.8% year over year) with net income of −$14M.

Q3 2026 key financials · XBRL

Revenue
$14M
−5.8% YoY · −11.9% QoQ
Net income
−$14M
−10.0% YoY · −0.8% QoQ
Operating margin
-94.3%
Gross margin
86.7%
EPS (diluted)
−$0.52
−6.1% YoY · +1.9% QoQ

Source: XBRL data from the CVRx, Inc. (CVRX) Q3 2026 10-Q on SEC EDGAR. USD.

CVRx, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $13.8M, down 6% YoY from $14.7M
  • Gross margin 87% vs 87% YoY; net loss $14.2M vs $12.9M
  • U.S. revenue $13.0M, down 4%; Europe weakest, $0.9M, down 27%
  • Cash $58.7M vs $75.7M at December 31, 2025; nine-month operating cash use $31.9M
  • Near-term headwinds: lower sales productivity, payer approval declines, specialist turnover; expense reductions implemented

Risk Factors

  • No material changes to risk factors disclosed in the December 31, 2025 Form 10-K
  • Regulatory risk: Continued compliance obligations for medical-device operations
  • Operational risk: Dependence on successful commercialization of CVRx products
  • Financial risk: Potential need for additional capital to fund operations and growth

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other CVRx, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.